300003.SZ
乐普医疗
SZSE · Healthcare · C 制造业 · CN
CNY 11.71
−3.78%Year over year
Reported trailing growth
- Revenue
- +8.5%
- EBITDA
- —
- EBIT
- +804.3%
- EPS
- +477.8%
- Free cash flow
- +67.4%
- Operating cash flow
- +35.6%
Forward estimates
Based on analyst estimates
- Revenue
- +10.3%
- EBITDA
- +6.4%
- EPS
- +1.9%
Three-year CAGR
- Revenue
- -15.1%
- EBITDA
- -15.4%
- EBIT
- -22.5%
- Net income
- -24.1%
- EPS
- -24.7%
- Free cash flow
- -22.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026